期刊
FUTURE ONCOLOGY
卷 11, 期 13, 页码 1977-1991出版社
FUTURE MEDICINE LTD
DOI: 10.2217/FON.15.92
关键词
computed tomography; Hodgkin lymphoma; lymphoma; minimal residual disease; non-Hodgkin lymphoma; PET; surveillance
类别
资金
- CR Flowers' National Cancer Institute [R21 CA158686]
While remission and cure rates for Hodgkin and non-Hodgkin lymphoma continue to improve, surveillance approaches remain controversial, especially in light of recent reports suggesting limited benefit for routine radiologic assessment. Routine cross-sectional imaging results in considerable patient expense and anxiety, and this approach does not clearly improve patient outcomes. Next-generation approaches including minimal residual disease detection may provide an opportunity to identify relapse early and intervene prior to progression of clinical disease. This review discusses the role of surveillance imaging in Hodgkin and non-Hodgkin lymphoma and provides an introduction to serologic assessment of minimal residual disease. Future studies will need to focus on the clinical application of minimal residual disease surveillance and its ability to predict relapse, treatment response and survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据